[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 13",
    "summary": "Read our weekly summary for companies which changed their dividends, stocks with upcoming ex-dividend dates, and companies with upcoming pay dates.",
    "url": "https://finnhub.io/api/news?id=5b34acd3126724038a16d4d87babf7ac15d7848a2942daa99152d2b8c81edf6c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752258545,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 13",
      "id": 135885054,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "PG",
      "source": "SeekingAlpha",
      "summary": "Read our weekly summary for companies which changed their dividends, stocks with upcoming ex-dividend dates, and companies with upcoming pay dates.",
      "url": "https://finnhub.io/api/news?id=5b34acd3126724038a16d4d87babf7ac15d7848a2942daa99152d2b8c81edf6c"
    }
  },
  {
    "ts": null,
    "headline": "Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=ef5d01d71ef9cee3cb6ceccb4120f8c3ab3b9433bdf069f666f9680565a7ae3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752238803,
      "headline": "Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 135883474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PG",
      "source": "Yahoo",
      "summary": "P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=ef5d01d71ef9cee3cb6ceccb4120f8c3ab3b9433bdf069f666f9680565a7ae3a"
    }
  },
  {
    "ts": null,
    "headline": "Third Time's The Charm: Northern District Of California Dismisses \"Pure Cotton\" PFAS Advertising Suit — With Prejudice",
    "summary": "On July 1, 2025, the U.S. District Court for the Northern District of California entered a final judgment in favor of Procter & Gamble Co., bringing an end to a putative class action alleging that the...",
    "url": "https://finnhub.io/api/news?id=cafab1db4d47aa520dead7765d3419a5ebe1aa9d3f13befaa59a3580707b68ff",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752228610,
      "headline": "Third Time's The Charm: Northern District Of California Dismisses \"Pure Cotton\" PFAS Advertising Suit — With Prejudice",
      "id": 135878718,
      "image": "",
      "related": "PG",
      "source": "Finnhub",
      "summary": "On July 1, 2025, the U.S. District Court for the Northern District of California entered a final judgment in favor of Procter & Gamble Co., bringing an end to a putative class action alleging that the...",
      "url": "https://finnhub.io/api/news?id=cafab1db4d47aa520dead7765d3419a5ebe1aa9d3f13befaa59a3580707b68ff"
    }
  },
  {
    "ts": null,
    "headline": "Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong",
    "summary": "Functional dyspepsia, marked by untraceable upper abdominal discomfort, is seeing innovation through pharmacological treatments, lifestyle changes, and alternative therapies like herbal and microbiome modulation. Investment in digital health and GI research is boosting symptom management, while refined diagnostic criteria aid identification. Challenges such as symptom overlap and treatment limitations persist, yet AI-driven patient solutions are promising. North America leads the market due to a",
    "url": "https://finnhub.io/api/news?id=36ac6442334db3f149c0228fac6b5d950b19662ae2f1086e8f0d2e4aeb53b4c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752222060,
      "headline": "Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong",
      "id": 135874539,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PG",
      "source": "Yahoo",
      "summary": "Functional dyspepsia, marked by untraceable upper abdominal discomfort, is seeing innovation through pharmacological treatments, lifestyle changes, and alternative therapies like herbal and microbiome modulation. Investment in digital health and GI research is boosting symptom management, while refined diagnostic criteria aid identification. Challenges such as symptom overlap and treatment limitations persist, yet AI-driven patient solutions are promising. North America leads the market due to a",
      "url": "https://finnhub.io/api/news?id=36ac6442334db3f149c0228fac6b5d950b19662ae2f1086e8f0d2e4aeb53b4c7"
    }
  }
]